Shahzaib Ihsan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Shahzaib Ihsan has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Masab Ali
Department of Internal Medicine MedStar Health Georgetown University Baltimore Maryland USA
2 shared publications - Muhammad Husnain Ahmad
S Tentishev Asian Medical Institute Kant Kyrgyzstan
2 shared publications - Muhammad Umar Shahid
Department of Internal Medicine Faisalabad Medical University Faisalabad Punjab Pakistan
2 shared publications - Aasim Ali
Neurology Department Allied Hospital Faisalabad Faisalabad Pakistan
1 shared publication - Abdullah Zaheer
Department of Internal Medicine, Faisalabad Medical University, Faisalabad, Punjab, Pakistan
1 shared publication - Ahmad Mbbs Zia
Department of Internal Medicine, Faisalabad Medical University, Faisalabad, Punjab, Pakistan
1 shared publication
Latest Publications
- Open Access
- 1 October 2026
- Published by Wiley in Journal of Arrhythmia
- Vol. 42 (5) , e70467
Trends and Demographic Disparities Among Adults With Sudden Cardiac Death and Diabetes Mellitus in the United States: A Nationwide Analysis
Background: Sudden cardiac death (SCD) represents a major cause of cardiovascular mortality, with diabetes mellitus (DM) significantly increasing susceptibility. However, long‐term national trends and demographic disparities in SCD among decedents with co‐documented SCD and DM remain insufficiently characterized. Methods: We conducted a retrospective analysis using the CDC WONDER database from 1999 to 2020. Adults with SCD and DM listed on death certificates were included. Age‐adjusted mortality rates (AAMRs) per 100 000 population were calculated and stratified by sex, age group, race/ethnicity, census region, state, and urbanization status. Temporal trends were assessed using annual percent changes (APCs), with p < 0.05 considered statistically significant. Results: A total of 51 756 deaths among decedents with co‐documented SCD and DM were identified. Overall AAMR increased from 1.29 in 1999 to 1.46 in 2020 (APC +0.46%, p = 0.012). Men had significantly higher mortality than women. Older adults (≥ 75 years) exhibited the highest mortality burden, though relative increases were notable in younger groups. Black individuals had the highest mortality, with a sharp rise in 2020. Rural populations experienced higher mortality than urban counterparts, with significant upward trends. Southern states demonstrated the highest regional burden. Conclusion: The population‐level burden of co‐documented SCD and DM in the United States has increased modestly over the past two decades, with significant demographic and geographic disparities. Targeted public health interventions and equitable cardiovascular risk management are urgently needed to reduce these disparities.
- 1 October 2026
- Published by Wiley in Journal of Arrhythmia
- Vol. 42 (5) , e70467
Open AccessTrends and Demographic Disparities Among Adults With Sudden Cardiac Death and Diabetes Mellitus in the United States: A Nationwide Analysis
Background: Sudden cardiac death (SCD) represents a major cause of cardiovascular mortality, with diabetes mellitus (DM) significantly increasing susceptibility. However, long‐term national trends and demographic disparities in SCD among decedents with co‐documented SCD and DM remain insufficiently characterized. Methods: We conducted a retrospective analysis using the CDC WONDER database from 1999 to 2020. Adults with SCD and DM listed on death certificates were included. Age‐adjusted mortality rates (AAMRs) per 100 000 population were calculated and stratified by sex, age group, race/ethnicity, census region, state, and urbanization status. Temporal trends were assessed using annual percent changes (APCs), with p < 0.05 considered statistically significant. Results: A total of 51 756 deaths among decedents with co‐documented SCD and DM were identified. Overall AAMR increased from 1.29 in 1999 to 1.46 in 2020 (APC +0.46%, p = 0.012). Men had significantly higher mortality than women. Older adults (≥ 75 years) exhibited the highest mortality burden, though relative increases were notable in younger groups. Black individuals had the highest mortality, with a sharp rise in 2020. Rural populations experienced higher mortality than urban counterparts, with significant upward trends. Southern states demonstrated the highest regional burden. Conclusion: The population‐level burden of co‐documented SCD and DM in the United States has increased modestly over the past two decades, with significant demographic and geographic disparities. Targeted public health interventions and equitable cardiovascular risk management are urgently needed to reduce these disparities.
- Open Access
- 31 July 2026
- Published by Wolters Kluwer Health in Medicine
- Vol. 105 (31) , e49969
Mortality among U.S. adults with coexisting type 2 diabetes mellitus and malignant neoplasms: A nationwide observational study (1999–2024)
Type 2 diabetes mellitus (T2DM) and malignant neoplasms are among the most prevalent chronic diseases worldwide. When coexisting, they substantially increase morbidity and mortality. However, national trends in mortality among patients with coexisting T2DM and malignant neoplasms in the United States remain underexplored. We analyzed U.S. death certificates from the CDC WONDER database for individuals aged ≥ 25 years who died between 1999 and 2024 with both T2DM and malignant neoplasms listed anywhere on the death certificate (underlying or contributing causes). Age-adjusted mortality rates (AAMRs) and annual percent change (APC) were calculated by year, sex, age group, race/ethnicity, geographic region, and urbanization status. From 1999 to 2024, 357,910 U.S. deaths occurred among individuals in whom both Type 2 Diabetes Mellitus and Malignant Neoplasms were listed on the death certificate. The AAMR rose from 6.37 to 17.2 per 100,000, with an overall APC of + 3.84%. Men exhibited higher mortality than women. Older adults bore the greatest burden, though middle-aged adults also showed a sharp proportional rise. Hispanic and Asian populations experienced the steepest increases. The West region showed the most pronounced growth. State-level variation exceeded fivefold, with Nebraska reporting the highest AAMR and Nevada the lowest. nonmetropolitan areas maintained higher mortality throughout, but metropolitan areas demonstrated a steeper rise, narrowing the rural–urban gap. Mortality among individuals with coexisting T2DM and malignant neoplasms has risen substantially in the U.S., with disproportionate increases among men, minority populations, and urban residents. These findings highlight the urgent need for integrated strategies addressing diabetes control, cancer prevention, and health equity across demographic and geographic subgroups.
- 31 July 2026
- Published by Wolters Kluwer Health in Medicine
- Vol. 105 (31) , e49969
Open AccessMortality among U.S. adults with coexisting type 2 diabetes mellitus and malignant neoplasms: A nationwide observational study (1999–2024)
Type 2 diabetes mellitus (T2DM) and malignant neoplasms are among the most prevalent chronic diseases worldwide. When coexisting, they substantially increase morbidity and mortality. However, national trends in mortality among patients with coexisting T2DM and malignant neoplasms in the United States remain underexplored. We analyzed U.S. death certificates from the CDC WONDER database for individuals aged ≥ 25 years who died between 1999 and 2024 with both T2DM and malignant neoplasms listed anywhere on the death certificate (underlying or contributing causes). Age-adjusted mortality rates (AAMRs) and annual percent change (APC) were calculated by year, sex, age group, race/ethnicity, geographic region, and urbanization status. From 1999 to 2024, 357,910 U.S. deaths occurred among individuals in whom both Type 2 Diabetes Mellitus and Malignant Neoplasms were listed on the death certificate. The AAMR rose from 6.37 to 17.2 per 100,000, with an overall APC of + 3.84%. Men exhibited higher mortality than women. Older adults bore the greatest burden, though middle-aged adults also showed a sharp proportional rise. Hispanic and Asian populations experienced the steepest increases. The West region showed the most pronounced growth. State-level variation exceeded fivefold, with Nebraska reporting the highest AAMR and Nevada the lowest. nonmetropolitan areas maintained higher mortality throughout, but metropolitan areas demonstrated a steeper rise, narrowing the rural–urban gap. Mortality among individuals with coexisting T2DM and malignant neoplasms has risen substantially in the U.S., with disproportionate increases among men, minority populations, and urban residents. These findings highlight the urgent need for integrated strategies addressing diabetes control, cancer prevention, and health equity across demographic and geographic subgroups.